Cargando…
Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
Peripheral T-cell lymphomas (PTCLs) are a group of very aggressive non-Hodgkin's lymphomas (NHLs) with poor prognoses and account for a majority of T-cell malignancies. Overall, the standard of care for patients with T-cell malignancies is poorly established, and there is an urgent clinical nee...
Autores principales: | Pinz, Kevin G., Yakaboski, Elizabeth, Jares, Alexander, Liu, Hua, Firor, Amelia E., Chen, Kevin H., Wada, Masayuki, Salman, Huda, Tse, William, Hagag, Nabil, Lan, Fengshuo, Leung, Elaine Lai-Han, Jiang, Xun, Ma, Yupo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762550/ https://www.ncbi.nlm.nih.gov/pubmed/29348865 http://dx.doi.org/10.18632/oncotarget.22626 |
Ejemplares similares
-
Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
por: Chen, Kevin H., et al.
Publicado: (2016) -
Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells
por: Salman, Huda, et al.
Publicado: (2019) -
Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia
por: Petrov, Jessica C., et al.
Publicado: (2018) -
Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells
por: Feng, Jia, et al.
Publicado: (2022) -
Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR
por: Zhang, Wenli, et al.
Publicado: (2021)